CORRECTION: Theranos executives charged by SEC for 'massive fraud'
Correction: In a recent post that appeared in the Filing Cabinet, we incorrectly connected a recent enforcement action against Theranos founder and CEO Elizabeth Holmes with Mylan, the maker of the EpiPen. Any implication or connection between the two companies was incorrect.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefBuy now, pay later firms catch a break as CFPB backs off enforcement
The U.S. Consumer Financial Protection Bureau (CFPB) signaled a softer regulatory approach last month, easing its investigation of financial firms following the U.S. government’s broader efforts under President Donald Trump to scale back regulatory enforcement on businesses. The agency reaffirmed this pivot as it will ease scrutiny of “Buy Now, ...
-
News BriefFinCEN proposes bar on Cambodian company due to alleged money laundering
A Cambodian financial company, the Huione Group, has laundered billions of dollars for international criminals and those linked to North Korea, according to the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN). The agency proposes that the company should be severed from having access to the U.S. financial ...
-
News BriefUBS to pay $511 million fine over Credit Suisse tax case, exposing compliance gaps
A significant settlement in a U.S. tax fraud case against Credit Suisse contains numerous compliance lessons related to beneficial ownership and due diligence in mergers and acquisitions.